FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385568163> ?p ?o ?g. }

• W4385568163 abstract "Abstract CK2 is considered a constitutively active protein kinase promoting/supporting several neoplastic properties and inducing a so-called non-oncogene addiction in tumor cells. Compared to the extensive body of pre-clinical research, the translational and clinical information on CK2 is still limited. The holoenzyme, composed by a tetrameric array of two catalytic (CSNK2A1 and/or CSNK2A1) and two regulatory (CSNK2B) subunits, remains to be clinically validated. Herein, we interrogated available cancer multiomics databases to unravel CK2 deregulated expression in NSCLC. We focused our analysis on individual CK2 subunits assuming subunit-specific tumor supportive roles across cancers and particularly, within two major NSCLC subtypes. Moreover, we performed meta-analysis to uncover associations between CK2 expression and patient survival, as well as further correlations analysis with components of the tumor-microenvironment. The genomic and transcriptomic data analysis was complemented by IHC evaluation of CSNK2A1, CSNK2A2 and CSNK2B subunit expression, and CK2 enzymatic activity thereof. Overall, our data suggests that epigenetic, transcriptional and post-transcriptional regulatory mechanisms rather than mutational/gene amplification events may account for differential CK2 subunits expression/activity in NSCLC. Of note, CSNK2A1 and CSNK2B mRNA up-regulation consistently determine a worse patient prognosis in LUAD and correlated with increased infiltration of MDSCs/CAFs. Importantly, we corroborated that CK2 protein subunits levels and enzymatic activity are significantly exacerbated in LUAD and LUSC, but only CSNK2A1 positively correlated with tumor size and disease stage in the analyzed patient cohort, thus supporting our transcriptomic-based correlation analysis. Finally, we concluded that CSNK2A1 alone and/or the homo-tetramer thereof may be more instrumental to support NSCLC than CSNK2A2; thus, tailored drugs against these molecular CK2 entities may achieve better therapeutic windows at least for advanced lung cancer treatment." @default.
• W4385568163 created "2023-08-05" @default.
• W4385568163 creator A5013150562 @default.
• W4385568163 creator A5027303541 @default.
• W4385568163 creator A5028868174 @default.
• W4385568163 creator A5037989560 @default.
• W4385568163 creator A5056742440 @default.
• W4385568163 creator A5059913318 @default.
• W4385568163 creator A5074635499 @default.
• W4385568163 creator A5076601235 @default.
• W4385568163 creator A5092595897 @default.
• W4385568163 date "2023-08-04" @default.
• W4385568163 modified "2023-10-01" @default.
• W4385568163 title "On Casein Kinase-2 (CK2) deregulation in NSCLC: an enzyme subunit-centered approach" @default.
• W4385568163 cites W1569230956 @default.
• W4385568163 cites W1943347991 @default.
• W4385568163 cites W1981387221 @default.
• W4385568163 cites W2004150448 @default.
• W4385568163 cites W2006411424 @default.
• W4385568163 cites W2017985095 @default.
• W4385568163 cites W2030040354 @default.
• W4385568163 cites W2030728569 @default.
• W4385568163 cites W2033433713 @default.
• W4385568163 cites W2036537353 @default.
• W4385568163 cites W2092516825 @default.
• W4385568163 cites W2095678992 @default.
• W4385568163 cites W2106139478 @default.
• W4385568163 cites W2114843025 @default.
• W4385568163 cites W2148990487 @default.
• W4385568163 cites W2149441684 @default.
• W4385568163 cites W2168102484 @default.
• W4385568163 cites W2271868513 @default.
• W4385568163 cites W2338870705 @default.
• W4385568163 cites W2405304057 @default.
• W4385568163 cites W2472885775 @default.
• W4385568163 cites W2546466212 @default.
• W4385568163 cites W2581414232 @default.
• W4385568163 cites W2588074452 @default.
• W4385568163 cites W2594218383 @default.
• W4385568163 cites W2736730167 @default.
• W4385568163 cites W2741508285 @default.
• W4385568163 cites W2773444415 @default.
• W4385568163 cites W2818354613 @default.
• W4385568163 cites W2884918631 @default.
• W4385568163 cites W2892098711 @default.
• W4385568163 cites W2899158325 @default.
• W4385568163 cites W2903902446 @default.
• W4385568163 cites W2918854355 @default.
• W4385568163 cites W2950993016 @default.
• W4385568163 cites W2954773460 @default.
• W4385568163 cites W2960854464 @default.
• W4385568163 cites W2965206386 @default.
• W4385568163 cites W2970358232 @default.
• W4385568163 cites W3006500278 @default.
• W4385568163 cites W3027286012 @default.
• W4385568163 cites W3028304854 @default.
• W4385568163 cites W3047825284 @default.
• W4385568163 cites W3083364634 @default.
• W4385568163 cites W3091803637 @default.
• W4385568163 cites W3100790266 @default.
• W4385568163 cites W3119141737 @default.
• W4385568163 cites W3119977270 @default.
• W4385568163 cites W3122350294 @default.
• W4385568163 cites W3125457212 @default.
• W4385568163 cites W3127789712 @default.
• W4385568163 cites W3135882325 @default.
• W4385568163 cites W3136929512 @default.
• W4385568163 cites W3155736945 @default.
• W4385568163 cites W3162383196 @default.
• W4385568163 cites W3171648992 @default.
• W4385568163 cites W3184524984 @default.
• W4385568163 cites W3210674384 @default.
• W4385568163 cites W3211988828 @default.
• W4385568163 cites W3216267485 @default.
• W4385568163 cites W358487051 @default.
• W4385568163 cites W4250786259 @default.
• W4385568163 cites W4281289615 @default.
• W4385568163 cites W4288077642 @default.
• W4385568163 cites W4291415522 @default.
• W4385568163 cites W4292291640 @default.
• W4385568163 cites W4296120037 @default.
• W4385568163 cites W4311069767 @default.
• W4385568163 cites W4311682342 @default.
• W4385568163 cites W4313260614 @default.
• W4385568163 cites W4313584627 @default.
• W4385568163 cites W4321317624 @default.
• W4385568163 doi "https://doi.org/10.1101/2023.08.04.551954" @default.
• W4385568163 hasPublicationYear "2023" @default.
• W4385568163 type Work @default.
• W4385568163 citedByCount "0" @default.
• W4385568163 crossrefType "posted-content" @default.
• W4385568163 hasAuthorship W4385568163A5013150562 @default.
• W4385568163 hasAuthorship W4385568163A5027303541 @default.
• W4385568163 hasAuthorship W4385568163A5028868174 @default.
• W4385568163 hasAuthorship W4385568163A5037989560 @default.
• W4385568163 hasAuthorship W4385568163A5056742440 @default.
• W4385568163 hasAuthorship W4385568163A5059913318 @default.
• W4385568163 hasAuthorship W4385568163A5074635499 @default.
• W4385568163 hasAuthorship W4385568163A5076601235 @default.
• W4385568163 hasAuthorship W4385568163A5092595897 @default.

• next